JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M311725200 on November 24, 2003

J. Biol. Chem., Vol. 279, Issue 8, 6893-6904, February 20, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/8/6893    most recent
M311725200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolski-Andreaco, A.
Right arrow Articles by Chandy, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolski-Andreaco, A.
Right arrow Articles by Chandy, K. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

SK3-1C, a Dominant-negative Suppressor of SKCa and IKCa Channels*

Aaron Kolski-Andreaco{ddagger}§, Hiroaki Tomita¶, Vikram G. Shakkottai{ddagger}||, George A. Gutman**, Michael D. Cahalan{ddagger}, J. Jay Gargus {ddagger}{ddagger}{ddagger}, and K. George Chandy{ddagger}§§

From the {ddagger}Physiology and Biophysics,Psychiatry and Human Behavior,**Microbiology and Molecular Genetics, and {ddagger}{ddagger}Pediatrics, University of California Irvine, Irvine, California 92697

Small conductance Ca2+-activated K+ channels, products of the SK1-SK3 genes, regulate membrane excitability both within and outside the nervous system. We report the characterization of a SK3 variant (SK3-1C) that differs from SK3 by utilizing an alternative first exon (exon 1C) in place of exon 1A used by SK3, but is otherwise identical to SK3. Quantitative RT-PCR detected abundant expression of SK3-1C transcripts in human lymphoid tissues, skeletal muscle, trachea, and salivary gland but not the nervous system. SK3-1C did not produce functional channels when expressed alone in mammalian cells, but suppressed SK1, SK2, SK3, and IKCa1 channels, but not BKCa or KV channels. Confocal microscopy revealed that SK3-1C sequestered SK3 protein intracellularly. Dominant-inhibitory activity of SK3-1C was not due to a nonspecific calmodulin sponge effect since overexpression of calmodulin did not reverse SK3-1C-mediated intracellular trapping of SK3 protein, and calmodulin-Ca2+-dependent inactivation of CaV channels was not affected by SK3-1C overexpression. Deletion analysis identified a dominant-inhibitory segment in the SK3-1C C terminus that resembles tetramerization-coiled-coiled domains reported to enhance tetramer stability and selectivity of multimerization of many K+ channels. SK3-1C may therefore suppress calmodulin-gated SKCa/IKCa channels by trapping these channel proteins intracellularly via subunit interactions mediated by the dominant-inhibitory segment and thereby reduce functional channel expression on the cell surface. Such family-wide dominant-negative suppression by SK3-1C provides a powerful mechanism to titrate membrane excitability and is a useful approach to define the functional in vivo role of these channels in diverse tissues by their targeted silencing.


Received for publication, October 27, 2003 , and in revised form, November 20, 2003.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF438203.

* This work was supported by grants from the National Institutes of Health (MH59222), Rockefeller Brothers Fund (to K. G. C.), and National Ataxia Foundation (to K. G. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by a National Institutes of Health predoctoral training grant in cellular and molecular neuroscience (1T32 N507444).

|| Supported by a predoctoral fellowship from the American Heart Association Western States Affiliate.

§§ To whom correspondence should be addressed: Dept. of Physiology and Biophysics, Room 291, Joan Irvine Smith Hall, College of Medicine, University of California, Irvine, CA 92697. Tel.: 949-824-2133; Fax: 949-824-3143; E-mail: gchandy{at}uci.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. S. Thorneloe, A. M. Knorn, P. E. Doetsch, E. S. R. Lashinger, A. X. Liu, C. T. Bond, J. P. Adelman, and M. T. Nelson
Small-conductance, Ca2+-activated K+ channel 2 is the key functional component of SK channels in mouse urinary bladder
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1737 - R1743.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Potier, V. Joulin, S. Roger, P. Besson, M.-L. Jourdan, J.-Y. LeGuennec, P. Bougnoux, and C. Vandier
Identification of SK3 channel as a new mediator of breast cancer cell migration.
Mol. Cancer Ther., November 1, 2006; 5(11): 2946 - 2953.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Tuteja, D. Xu, V. Timofeyev, L. Lu, D. Sharma, Z. Zhang, Y. Xu, L. Nie, A. E Vazquez, J. N. Young, et al.
Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2714 - H2723.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Schmitz, A. Sankaranarayanan, P. Azam, K. Schmidt-Lassen, D. Homerick, W. Hansel, and H. Wulff
Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases
Mol. Pharmacol., November 1, 2005; 68(5): 1254 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Beeton, M. W. Pennington, H. Wulff, S. Singh, D. Nugent, G. Crossley, I. Khaytin, P. A. Calabresi, C.-Y. Chen, G. A. Gutman, et al.
Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases
Mol. Pharmacol., April 1, 2005; 67(4): 1369 - 1381.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Villalobos, V. G. Shakkottai, K. G. Chandy, S. K. Michelhaugh, and R. Andrade
SKCa Channels Mediate the Medium But Not the Slow Calcium-Activated Afterhyperpolarization in Cortical Neurons
J. Neurosci., April 7, 2004; 24(14): 3537 - 3542.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.